Skip to main content
Publications
Brufsky A, Sandin R, Stergiopoulos S, Chen C, Karanth S , Li B, Esterberg L , Makari D, Candrilli S , Goyal R , Rugo H. Overall survival with palbociclib (PAL) plus an aromatase inhibitor (AI) versus AI alone in older patients (pts) with de novo, HR+/HER2− metastatic breast cancer: a SEER-Medicare analysis . Poster to be given at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting; May 31, 2024. Chicago, IL.
Mordin M , Bhogal P , Warttig S , Gildea L , Long J , D'Souza V , Kinderas M , Ling C , Hartley L . HTA requirements for medical technologies in Canada . Poster presented at the ISPOR 2024; May 7, 2024. Atlanta, GA.
Mordin M , Bhogal P , Warttig S , Gildea L , Long J , D'Souza V , Kinderas M , Ling C , Hartley L . What is the medical technology HTA process in Japan? Poster presented at the ISPOR 2024; May 6, 2024. Atlanta, GA.
Gannon PR, MacKay RE , Love KL, Weaver BW, Burke KB, Dotto VR, Garcia JM, Luciano A, Berryhill BA, Mumma JM. Connecting pathogen transmission and performance of the WHO's 'my 5 moments of hand hygiene' in a high-fidelity simulation . Poster presented at the Society for Healthcare Epidemiology of America (SHEA) Spring Conference; April 19, 2024. Houston, TX.
Neal J, Lee JB, Ahn MJ, Ariyasu R, nash C, Smith D, Nagar S , Jimenez M , Kahangire DA, Kim YJ, Nasirova F, Lin S. Treatment (tx) patterns and clinical outcomes in unresectable stage III epidermal growth factor receptor-mutation positive (EGFRm) non-small cell lung cancer (NSCLC) treated with chemoradiotherapy (CRT): interim analysis of a global real-world (RW) study . Poster presented at the European Lung Cancer Congress (ELCC) 2024; March 20, 2024. Prague, Czech Republic.
Craig T, Baptist AP, Anderson J, Vanegas A , Schultz BG, Blair C, Sing K, Juethner S. Quality of life among patients with hereditary angioedema within underrepresented racial or ethnic groups . Poster presented at the Western Society of Allergy, Asthma & Immunology (WSAAI) 2024 Annual Meeting; February 4, 2024. Koloa, HI.
Dolin P, Kielar D, Shavit A, Keogh K, Rowell J, Edmonds C, Meyers J , Esterberg L , Nham T , Chen S. Disease burden or eosinophilic granulomatosis with polyangiitis (EGPA): a retrospective analysis of US health insurance claims data . Poster presented at the American College of Rheumatology (ACR) Convergence 2023; November 13, 2023. San Diego, CA.
Dolin P, Kielar D, Shavit A, Keogh K, Rowell J, Edmonds C, Meyers J , Esterberg L , Nham T , Chen S. Diagnosis pathways in patients with eosinophilic granulomatosis with polyangiitis (EGPA): a retrospective analysis of US health insurance claims data . Poster presented at the American College of Rheumatology (ACR) Convergence 2023; November 13, 2023. San Diego, CA. Previously presented at the Eastern Pulmonary Conference.
Dolin P, Kielar D, Shavit A, Keogh K, Rowell J, Edmonds C, Meyers J , Esterberg L , Nham T , Chen S. Treatment patterns for eosinophilic granulomatosis with polyangiitis (EGPA): a retrospective analysis of US health insurance claims data . Poster presented at the American College of Rheumatology (ACR) Convergence 2023; November 13, 2023. San Diego, CA.
Clevenger C, Brubaker M, Patel M, Cummings J, Jackson WC, Stroud C, Pechin S, Bratlee-Whitaker E , Brown TM , Fehnel S , Grossberg G. One minute to recognition: the agitation in Alzheimer's screener for caregivers (AASC) . Poster presented at the Gerontological Society of America's 2023 Annual Scientific Meeting; November 10, 2023. Tampa, FL.
Oberprieler NG, Kovesdy CP, Layton JB , Gay A, Farjat AE, Liu F, Johannes CB , Pladevall-Vila M , Vizcaya D. Early use and effectiveness of finerenone in US patients with CKD and type 2 diabetes: a FOUNTAIN platform analysis . Poster presented at the Kidney Week 2023; November 2, 2023. Philadelphia, PA.